)
)
Pyxis Oncology Inc Investor Relations Material
Latest events
Status Update
Pyxis Oncology Inc
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Pyxis Oncology Inc
Access all reports
Pyxis Oncology Inc. is a clinical-stage biopharmaceutical company focused on developing therapies to treat cancer. It is focused on helping patients with cancer through a differentiated portfolio of biologics, specifically targeting tumor cells and overcoming immune suppression. Pyxis Oncology's strategy encompasses the use of antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies, aiming to improve outcomes for patients with difficult-to-treat cancers. The company is headquartered in Boston, MA, and its shares are listed on the Nasdaq.
Key slides for Pyxis Oncology Inc
Q2 2024
Pyxis Oncology Inc
Q2 2024
Pyxis Oncology Inc
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
PYXS
Country
🇺🇸 United States